Invite Health, Inc. – Trademark Portfolio
Entity Type: 03
Invite Health, Inc. holds 138 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 123 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 76 trademarks are registered. Notable registered marks include HX, TX, INVITE, FLEX HX, and PARA HX. The owner is based in New Hyde Park, NY.
1645A Jericho Turnpike
New Hyde Park, NY 11040
Showing of trademarks Trademarks
Trademark Classifications
Invite Health, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Invite Health, Inc. have?
Invite Health, Inc. has 138 U.S. trademarks filed with the USPTO. Of these, 76 registered, 29 abandoned, 33 cancelled.
What trademark classes does Invite Health, Inc. file in?
Invite Health, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Invite Health, Inc.'s most well-known trademarks?
Invite Health, Inc.'s registered trademark portfolio includes well-known marks such as HX, TX, INVITE, FLEX HX, and PARA HX. These are among 76 currently registered trademarks in the portfolio.
What is Invite Health, Inc.'s trademark registration success rate?
Invite Health, Inc. has a 55% trademark registration rate, with 76 out of 138 resolved applications resulting in successful registration. Currently, 0 applications are pending review.